Stem cell-derived extracellular vesicles may alleviate brain bleeding, preclinical study shows

Written by Harriet Wall

A preclinical study conducted by researchers at Sungkyunkwan University (Seoul, South Korea) has indicated that extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs) could alleviate intraventricular hemorrhage (IVH) damage – a devastating condition that commonly affects premature babies. Their research was recently published in the journal STEM CELLS Translational Medicine. Severe IVH can cause a build-up of fluid in the brain, resulting in an increase in pressure that can lead to seizures, cerebral palsy, developmental retardation and an increased mortality rate. Up until now, there have been no promising treatments for this disease on the horizon. MSCs have the...

To view this content, please register now for access

It's completely free